| Potential therapeutic targets of epithelial–mesenchymal transition in melanoma RL Pearlman, MKM de Oca, HC Pal, F Afaq Cancer letters 391, 125-140, 2017 | 161 | 2017 |
| Tea polyphenols for the prevention of UVB‐induced skin cancer P Sharma, MK Montes de Oca, AR Alkeswani, SF McClees, T Das, ... Photodermatology, photoimmunology & photomedicine 34 (1), 50-59, 2018 | 92 | 2018 |
| Phytochemicals for the prevention of photocarcinogenesis MK Montes de Oca, RL Pearlman, SF McClees, R Strickland, F Afaq Photochemistry and photobiology 93 (4), 956-974, 2017 | 66 | 2017 |
| Adnexal masses in pregnancy MKM de Oca, SK Dotters-Katz, JA Kuller, RA Previs Obstetrical & Gynecological Survey 76 (7), 437-450, 2021 | 17 | 2021 |
| Healthcare access dimensions and guideline-concordant ovarian cancer treatment: SEER-medicare analysis of the ORCHiD study MKM de Oca, LE Wilson, RA Previs, A Gupta, A Joshi, B Huang, M Pisu, ... Journal of the National Comprehensive Cancer Network 20 (11), 1255-1266. e11, 2022 | 14 | 2022 |
| Diversity and transparency in gynecologic oncology clinical trials MK Montes de Oca, EP Howell, D Spinosa, H Knochenhauer, BJ Peipert, ... Cancer Causes & Control 34 (2), 133-140, 2023 | 8 | 2023 |
| Distress screening in endometrial cancer leads to disparity in referral to support services HW Reid, G Broadwater, MKM de Oca, B Selvan, O Fayanju, ... Gynecologic oncology 164 (3), 622-627, 2022 | 8 | 2022 |
| Head and neck cancer PEG site metastases: Association with PEG placement method MK Montes de Oca, A Nye, C Porter, J Collins, C Satterfield, ... Head & Neck 41 (5), 1508-1516, 2019 | 8 | 2019 |
| Health-care access dimensions and ovarian cancer survival: SEER-Medicare analysis of the ORCHiD study MK Montes de Oca, Q Chen, E Howell, LE Wilson, C Meernik, RA Previs, ... JNCI Cancer Spectrum 7 (2), pkad011, 2023 | 7 | 2023 |
| Peripartum Pubic Symphysis Diastasis MK Anastasio, AT Anastasio, JA Kuller Obstetrical & Gynecological Survey 78 (6), 369-375, 2023 | 4 | 2023 |
| Antibody-drug conjugates in gynecologic cancers MK Anastasio, S Shuey, BA Davidson Current Treatment Options in Oncology 25 (1), 1-19, 2024 | 3 | 2024 |
| Adjuvant treatment and outcomes for patients with stage IIIA grade 1 endometrioid endometrial cancer MKM de Oca, BB Albright, AA Secord, LJ Havrilesky, HA Moss International Journal of Gynecologic Cancer 31 (12), 2021 | 3 | 2021 |
| Evaluation of the clinical Index of Stable febrile neutropenia risk stratification system for management of febrile neutropenia in gynecologic oncology patients KA Monuszko, B Albright, MKM De Oca, NTT Nguyen, LJ Havrilesky, ... Gynecologic Oncology Reports 37, 100853, 2021 | 3 | 2021 |
| Results and clinical utilization of foundation medicine molecular tumor profiling in uterine and ovarian cancers CH Watson, G Broadwater, J Wong, D Spinosa, MKM de Oca, M Datto, ... Targeted Oncology 16, 109-118, 2021 | 3 | 2021 |
| Healthcare access dimensions and uterine cancer survival: a national cancer database study MK Anastasio, A Gupta, TF Akinyemiju, RA Previs Frontiers in Oncology 13, 1263371, 2023 | 2 | 2023 |
| “You start feeling comfortable, you just start sharing:” A qualitative study of patient distress screening in Black and White patients with endometrial cancer HW Reid, B Selvan, MKM de Oca, M Falkovic, S Malone, LJ Fish, ... Gynecologic oncology 168, 166-175, 2023 | 2 | 2023 |
| Cryocompression to Reduce Peripheral Neuropathy in Gynecologic Cancer: A Randomized Controlled Trial MK Anastasio, S Unnithan, A Scott, T Hayes, S Shah, HA Moss, A Erkanli, ... Obstetrics & Gynecology, 10.1097, 2022 | 2 | 2022 |
| Pancreatic panniculitis as the initial presentation of intrahepatic cholangiocarcinoma MKM de Oca, RA Jamison JAAD Case Reports 4 (6), 528-530, 2018 | 2 | 2018 |
| Fisetin treatment reduces tumor growth and metastasis by modulating PI3K/AKT and MEK/ERK pathways in a BRAFV600E/PTENNULL mouse model of melanoma HC Pal, MKM Oca, P Sharma, RL Pearlman, F Afaq Cancer Research 77 (13_Supplement), 5107-5107, 2017 | 2 | 2017 |
| The doc versus the bot: A pilot study to assess the quality and accuracy of physician and chatbot responses to clinical questions in gynecologic oncology MK Anastasio, P Peters, J Foote, A Melamed, SC Modesitt, F Musa, ... Gynecologic Oncology Reports 55, 101477, 2024 | 1 | 2024 |
